Gölz Leonie, Lemcke Johannes, Meier Ullrich
Department of Neurosurgery, Unfallkrankenhaus Berlin, Warener Straße 7, 12686, Berlin, Germany.
Surg Neurol Int. 2013 Oct 15;4:140. doi: 10.4103/2152-7806.119879. eCollection 2013.
Modern ventriculoperitoneal shunts (VPS) are programmable, which enables clinicians to adjust valve-pressure according to their patients' individual needs. The aim of this retrospective analysis is to evaluate indications for valve-pressure adjustments in idiopathic normal pressure hydrocephalus (iNPH).
Patients operated between 2004 and 2011 diagnosed with iNPH were included. Kiefer-Scale was used to classify each patient. Follow-up exams were conducted 3, 6, and 12 months after shunt implantation and yearly thereafter. Initial valve-pressure was 100 or 70 mmH2O. Planned reductions of the valve-pressure to 70 and 50 mmH2O, respectively, were carried out and reactive adjustment of the valve-pressure to avoid over- and under-drainage were indicated.
A total of 52 patients were provided with a Medos-Hakim valve(Codman®) with a Miethke shunt-assistant(Aesculap®) and 111 patients with a Miethke-proGAV(Aesculap®). 180 reductions of the valve-pressure took place (65% reactive, 35% planned). Most patients (89%) needed one or two adjustments of their valve-pressures for optimal results. In 41%, an improvement of the symptoms was observed. Gait disorder was improved most often after valve-pressure adjustments (32%). 18 times an elevation of valve-pressure was necessary because of headaches, vertigo, or the development of subdural hygroma. Optimal valve-pressure for most patients was around 50 mmH2O (36%).
The goal of shunt therapy in iNPH should usually be valve-pressure settings between 30 and 70 mmH2O. Reactive adjustments of the valve-pressure are useful for therapy of over- and underdrainage symptoms. Planned reductions of the valve opening pressure are effective even if postoperative results are already satisfactory.
现代脑室腹腔分流术(VPS)是可编程的,这使临床医生能够根据患者的个体需求调整阀门压力。本回顾性分析的目的是评估特发性正常压力脑积水(iNPH)中阀门压力调整的指征。
纳入2004年至2011年间接受手术且诊断为iNPH的患者。使用Kiefer量表对每位患者进行分类。在分流植入后3、6和12个月以及此后每年进行随访检查。初始阀门压力为100或70 mmHg₂O。分别计划将阀门压力降至70和50 mmHg₂O,并根据需要对阀门压力进行反应性调整以避免引流过多和过少。
共有52例患者使用了带有Miethke分流辅助装置(Aesculap®)的Medos-Hakim阀门(Codman®),111例患者使用了Miethke-proGAV(Aesculap®)。共进行了180次阀门压力降低(65%为反应性调整,35%为计划性调整)。大多数患者(89%)需要对阀门压力进行一到两次调整以获得最佳效果。41%的患者症状得到改善。阀门压力调整后步态障碍改善最为常见(32%)。由于头痛、眩晕或硬膜下积液的出现,有18次需要提高阀门压力。大多数患者的最佳阀门压力约为50 mmHg₂O(36%)。
iNPH分流治疗的目标通常应为阀门压力设置在30至70 mmHg₂O之间。对阀门压力进行反应性调整有助于治疗引流过多和过少的症状。即使术后结果已经令人满意,计划性降低阀门开启压力也是有效的。